TB-500

TB-500 is a synthetic analogue of thymosin beta-4 studied in cytoskeletal and cell-migration research models. Experimental literature evaluates its interaction with actin dynamics and downstream processes associated with extracellular matrix remodeling and angiogenic signaling. Laboratory investigations characterize pathway-level effects in controlled cell-based and animal systems without implying human outcomes.

$65

Buy 2, Get GHK-Cu Free

What It Is	TB-500 is a synthetic 43–amino–acid peptide corresponding to the thymosin beta-4 (Tβ4) sequence motif and studied in laboratory research as an actin-binding peptide involved in cytoskeletal biology.
What It’s Derived From	TB-500 is derived from the endogenous thymosin beta-4 protein, a widely distributed actin-binding molecule. It represents a synthetic analogue used to investigate actin monomer (G-actin) sequestration and actin filament (F-actin) dynamics in experimental systems.
What Research Focuses On	Research evaluates TB-500 in in vitro and preclinical models examining cytoskeletal remodeling, cell migration dynamics, extracellular matrix (ECM) reorganization, angiogenesis-associated transcriptional programs, oxidative stress signaling, epithelial and stromal re-epithelialization kinetics, and tissue-remodeling endpoints under controlled laboratory conditions.

This product is indented for research purposes only. All product information is for educational purposes only. This product is not a drug, food or cosmetic.